Can extremely low cholesterol save more hearts? new trial aims to find out
NCT ID NCT07615296
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two cholesterol-lowering strategies in 6,000 Chinese patients with very high-risk heart disease. One group aims for ultra-low LDL cholesterol below 1.0 mmol/L, while the other targets a moderate level of 1.0-1.39 mmol/L. Researchers will track heart attacks, strokes, and deaths over up to 5 years, along with safety and cost. The goal is to see if pushing cholesterol extremely low offers extra protection without unacceptable side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lipid-lowering therapy (statins, ezetimibe, PCSK9 inhibitors)
- What this could lead to
- If successful, this could show that pushing LDL cholesterol extremely low provides better protection against heart attacks and strokes for high-risk patients, potentially changing treatment guidelines.
- What could go wrong
- This is an early-stage trial with no results yet. Ultra-low LDL-C may increase risks like cognitive decline or bleeding, and the benefit may not outweigh these risks. The study is also limited to Chinese patients, so results may not apply globally.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, 100029, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a drop of blood predict disease years before it strikes?
- Your smartwatch may predict a heart attack days before it happens
- Could an arthritis drug shield heart and kidneys in metabolic syndrome?
- Heart drug showdown: which statin spares your blood sugar?
- 3,000 volunteers to reveal hidden heart risks in qatar
- New hope for heart patients: pelacarsen available through special program